November 28, 2024 - 11:34

Cost-cutting efforts continue to bear fruit at Independence Health System, where its two largest subsidiaries delivered encouraging economic news recently. After facing a challenging financial landscape for the past two years, Excela Health has successfully reversed its trend of losses, marking a significant milestone in its recovery strategy.
The health system has implemented a series of strategic initiatives aimed at reducing operational costs while enhancing service delivery. These measures have not only stabilized the financial health of the organization but have also improved patient care and satisfaction levels. The leadership team expressed optimism about the future, highlighting that the positive financial results reflect the hard work and dedication of the entire staff.
As the organization continues to navigate the complexities of the healthcare market, it remains committed to maintaining fiscal responsibility while ensuring that quality care remains at the forefront of its mission. The turnaround serves as a testament to the resilience of the health system and its unwavering focus on sustainability and growth.
December 12, 2025 - 02:10
Senate Republicans Halt Efforts to Extend Health Insurance SubsidiesOn Thursday, Senate Republicans successfully blocked a motion aimed at advancing a Democratic proposal to prolong enhanced health insurance premium subsidies, which are set to expire at the end of...
December 11, 2025 - 08:03
WHO's New Pandemic Agreement: A Step Towards Equity in Global HealthOn May 20, 2025, the World Health Assembly reached a significant milestone by unanimously adopting the World Health Organization (WHO) Pandemic Agreement, an international treaty aimed at enhancing...
December 10, 2025 - 23:09
UAMS Expands Community Health Worker Training Initiative in ArkansasLITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) Institute for Community Health Innovation is set to enhance the community health worker (CHW) workforce in Arkansas with the...
December 10, 2025 - 04:47
FDA Initiates Safety Review of RSV Medications for Infants Amid Immunization ConcernsThe Food and Drug Administration (FDA) has announced a safety review of two medications designed to combat respiratory syncytial virus (RSV) in infants. This decision comes as scrutiny increases...